Skip to main content

Peer Review reports

From: Potential healthcare resource use and associated costs of every 2 month injectable cabotegravir plus rilpivirine long-acting regimen implementation in the Spanish National Healthcare System compared to daily oral HIV treatments

Original Submission
17 Jan 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
1 Apr 2024 Reviewed Reviewer Report
18 Apr 2024 Reviewed Reviewer Report - Silvia Nozza
15 May 2024 Reviewed Reviewer Report
30 May 2024 Author responded Author comments - Laura Amanda Vallejo Aparicio
Resubmission - Version 4
30 May 2024 Submitted Manuscript version 4
1 Jun 2024 Reviewed Reviewer Report
7 Jun 2024 Reviewed Reviewer Report
3 Jul 2024 Author responded Author comments - Laura Amanda Vallejo Aparicio
Resubmission - Version 5
3 Jul 2024 Submitted Manuscript version 5
4 Jul 2024 Author responded Author comments - Laura Amanda Vallejo Aparicio
Resubmission - Version 6
4 Jul 2024 Submitted Manuscript version 6
Publishing
5 Jul 2024 Editorially accepted
2 Aug 2024 Article published 10.1186/s12879-024-09595-4

You can find further information about peer review here.

Back to article page